New PET scan may predict kidney cancer aggressiveness
NCT ID NCT07346404
First seen Jan 18, 2026 · Last updated Jun 21, 2026 · Updated 23 times
Summary
This study tests whether a special PET scan using 82-Rb can tell how aggressive kidney cancer is without needing a biopsy or surgery. Researchers will scan 50 adults with suspected or confirmed kidney cancer before they have surgery, then compare the scan results to the actual tumor grade from the removed tissue. If the scan can reliably identify high-grade cancers, it could help doctors decide who needs immediate treatment and who can be monitored safely.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL CELL CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
AP-HP - hôpital européen Georges-Pompidou
Paris, France
-
AP-HP - hôpital européen Georges-Pompidou
Paris, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
82-Rb injection
What this could lead to
If successful, this could provide a non-invasive way to grade kidney cancer aggressiveness, potentially reducing unnecessary surgeries.
What could go wrong
This is a small, early-phase pilot study with only 50 participants. The PET scan may not accurately distinguish between low- and high-grade tumors, and results may not apply to all kidney cancer types.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.